Compounds > n,n-dimethylarginine
Page last updated: 2024-09-03

n,n-dimethylarginine and Branch Vein Occlusion

n,n-dimethylarginine has been researched along with Branch Vein Occlusion in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Binder, H; Closs, EI; Gericke, A; Habermeier, A; Pfeiffer, N; Ponto, KA; Rosner, AK; Scharrer, I1
Carru, C; Carta, F; Deiana, L; Gaspa, L; Pinna, A; Sotgia, S; Usai, MF; Zinellu, A; Zinellu, E1

Other Studies

2 other study(ies) available for n,n-dimethylarginine and Branch Vein Occlusion

ArticleYear
[Asymmetric dimethylarginine (ADMA) in retinal vein occlusion-Results from the Gutenberg RVO study].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2021, Volume: 118, Issue:7

    Topics: Aged; Arginine; Humans; Hypertension; Retinal Vein Occlusion; Risk Factors

2021
Increased plasma asymmetric dimethylarginine (ADMA) levels in retinal venous occlusive disease.
    Clinical chemistry and laboratory medicine, 2008, Volume: 46, Issue:3

    Topics: Aged; Arginine; Case-Control Studies; Cohort Studies; Cysteine; Female; Humans; Male; Middle Aged; Retinal Vein Occlusion; Risk Factors

2008